Literature DB >> 19349828

Hyperemia beneath evacuated acute subdural hematoma is frequent and prolonged in patients with an unfavorable outcome: a xe-computed tomographic study.

Arturo Chieregato1, Alberto Noto, Alessandra Tanfani, Giovanni Bini, Costanza Martino, Enrico Fainardi.   

Abstract

OBJECTIVE: To verify the values and the time course of regional cerebral blood flow (rCBF) in the cortex located beneath an evacuated acute subdural hematoma (SDH) and their relationship with neurological outcome.
METHODS: rCBF levels were measured in multiple regions of interest, by means of a Xe-computed tomographic technique, in the cortex underlying an evacuated SDH and contralaterally in 20 patients with moderate or severe traumatic brain injury and an evacuated acute SDH. Twenty-three patients with moderate or severe traumatic brain injury and an evacuated extradural hematoma or diffuse injury served as the control group. Outcome was evaluated by means of the Glasgow Outcome Scale at 12 months.
RESULTS: Values for the maximum (rCBFmax) and the mean of all rCBF levels in the cortex beneath the evacuated SDH were more frequently consistent with hyperemia. The side-to-side differences in the mean of all rCBF and rCBFmax levels between lesioned and nonlesioned hemispheres were greater in patients with evacuated SDH than in controls (P = 0.0013 and P = 0.0018, respectively). The side-to-side difference in the maximum rCBF value was higher in SDH patients with unfavorable outcomes than in controls at 24 to 96 hours and at 4 to 7 days and higher than in patients with favorable outcomes at 4 to 7 days. The widest side-to-side difference in rCBFmax value was more elevated in patients with an evacuated SDH with unfavorable outcome than in patients with a favorable outcome (P = 0.047), whereas no differences were found in controls. The SDH thickness and the associated midline shift were greater in patients with unfavorable outcomes than in those with favorable outcomes.
CONCLUSION: On average, hyperemic long-lasting rCBF values frequently occur in the cortex located beneath an evacuated SDH and seem to be associated with unfavorable outcome.

Entities:  

Mesh:

Year:  2009        PMID: 19349828     DOI: 10.1227/01.NEU.0000341872.17024.44

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  6 in total

1.  Xenon-enhanced cerebral blood flow at 28% xenon provides uniquely safe access to quantitative, clinically useful cerebral blood flow information: a multicenter study.

Authors:  A P Carlson; A M Brown; E Zager; K Uchino; M P Marks; C Robertson; G P Sinson; A Marmarou; H Yonas
Journal:  AJNR Am J Neuroradiol       Date:  2011-06-23       Impact factor: 3.825

2.  Should the neurointensive care management of traumatic brain injury patients be individualized according to autoregulation status and injury subtype?

Authors:  Ulf Johnson; Anders Lewén; Elisabeth Ronne-Engström; Tim Howells; Per Enblad
Journal:  Neurocrit Care       Date:  2014-10       Impact factor: 3.210

Review 3.  Surgical management of traumatic acute subdural hematoma in adults: a review.

Authors:  Hiroshi Karibe; Toshiaki Hayashi; Takayuki Hirano; Motonobu Kameyama; Atsuhiro Nakagawa; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2014-10-31       Impact factor: 1.742

4.  Endoscopically Treated Subacute Subdural Hematoma Presenting Postoperative Cerebral Hyperperfusion Syndrome: Chronological Changes of Cerebral Blood Flow on Arterial Spin Labeling and Subcortical Low Intensity on Fluid-attenuated Inversion Recovery Images.

Authors:  Masahito Katsuki; Norio Narita; Ohmi Watanabe; Siqi Cai; Naoya Ishida; Teiji Tominaga
Journal:  NMC Case Rep J       Date:  2021-08-26

Review 5.  Traumatic brain injury: pathophysiology for neurocritical care.

Authors:  Kosaku Kinoshita
Journal:  J Intensive Care       Date:  2016-04-27

Review 6.  Clinical Characteristics and Outcome in Elderly Patients with Traumatic Brain Injury: For Establishment of Management Strategy.

Authors:  Hiroshi Karibe; Toshiaki Hayashi; Ayumi Narisawa; Motonobu Kameyama; Atsuhiro Nakagawa; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-07-05       Impact factor: 1.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.